Chargement en cours...
Trametinib response in heavily pretreated high-grade ovarian cancer: One step towards precision medicine
Traditional treatment failure in recurrent ovarian cancer remains a challenge for clinicians. Tumor genetic testing is a promising tool which has been proved able to identify sensitivity profiles in patients affected by cancers. This may be helpful in choosing targeted systemic treatments, aiming to...
Enregistré dans:
| Publié dans: | Gynecol Oncol Rep |
|---|---|
| Auteurs principaux: | , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Elsevier
2020
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7042411/ https://ncbi.nlm.nih.gov/pubmed/32128357 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.gore.2020.100547 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|